Header Logo

Kyle Amber

TitleAssociate Professor
InstitutionRush University, Rush Medical College
DepartmentDermatology
AddressChicago IL 60612
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Guerrero-Juarez CF, Goyal PK, Amber KT. Targeting interleukin (IL)-4/IL-13 in immune checkpoint inhibitor-induced bullous pemphigoid: a cautionary note on the beneficial effect of T helper 2 immunity in melanoma and immunotherapy. Br J Dermatol. 2023 Dec 20; 190(1):137-138. PMID: 37703325.
      Citations:    
    2. Sulejmani P, Medhus EJ, Madu PN, Amber KT. Polymorphous Cutaneous Sarcoidosis With Excellent Response to Minocycline. Cureus. 2023 Oct; 15(10):e47902. PMID: 38034184.
      Citations:    
    3. Guerrero-Juarez CF, Schilf P, Li J, Zappia MP, Bao L, Patel PM, Gieseler-Tillmann J, Murthy S, Cole C, Sverdlov M, Frolov MV, Hashimoto T, Ishii N, R?licke T, Bieber K, Ludwig RJ, Sadik CD, Amber KT. C-type lectin receptor expression is a hallmark of neutrophils infiltrating the skin in epidermolysis bullosa acquisita. Front Immunol. 2023; 14:1266359. PMID: 37799716.
      Citations:    
    4. Negris OR, Emerson C, Amber KT. Raised Linear Plaques on the Back. Cutis. 2023 08; 112(2):E22-E23. PMID: 37820329.
      Citations:    
    5. Wei C, Datta PK, Siegerist F, Li J, Yashwanth S, Koh KH, Kriho NW, Ismail A, Luo S, Fischer T, Amber KT, Cimbaluk D, Landay A, Endlich N, Rappaport J, Hayek SS, Reiser J. SuPAR mediates viral response proteinuria by rapidly changing podocyte function. Nat Commun. 2023 07 21; 14(1):4414. PMID: 37479685.
      Citations:    
    6. Cole C, Amber KT. Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibition. J Eur Acad Dermatol Venereol. 2023 11; 37(11):e1339-e1340. PMID: 37421297.
      Citations:    
    7. Gasparini G, Amber KT, Cozzani E, Parodi A. Editorial: Autoimmune blistering diseases: advances in the understanding of pathogenesis and new therapeutic horizons. Front Med (Lausanne). 2023; 10:1243878. PMID: 37502359.
      Citations:    
    8. Dodson JA, Emerson C, Amber KT. Atrophische r?tlich-gelbe Papeln rund um den linken Unterschenkel. J Dtsch Dermatol Ges. 2023 07; 21(7):810-812. PMID: 37427729.
      Citations:    
    9. Naffouj S, Marrero-Rivera GE, Nordenstam J, Amber KT, Trivedi I. Cutaneous Crohn's disease after proctocolectomy for medically refractory colonic Crohn's disease: a case series and review of the literature. Ann Gastroenterol. 2023 Jul-Aug; 36(4):466-476. PMID: 37396002.
      Citations:    
    10. Dodson JA, Emerson C, Amber KT. Atrophic pink-to-yellow papules on the left lower leg. J Dtsch Dermatol Ges. 2023 07; 21(7):810-811. PMID: 37160711.
      Citations:    
    11. Cole C, Haber R, Amber KT. Diversity in autoimmune blistering disease clinical trials: a systematic review. Int J Dermatol. 2023 10; 62(10):e561-e562. PMID: 37057617.
      Citations:    
    12. Kridin K, Mruwat N, Amber KT, Ludwig RJ. Risk of infections in patients with pemphigus treated with rituximab vs. azathioprine or mycophenolate mofetil: a large-scale global cohort study. Br J Dermatol. 2023 03 30; 188(4):499-505. PMID: 36763798.
      Citations:    
    13. Hundt JE, Hoffmann MH, Amber KT, Ludwig RJ. Editorial: Autoimmune pre-disease. Front Immunol. 2023; 14:1159396. PMID: 36865538.
      Citations:    
    14. Cole C, Amber KT. Off-Label Uses of Rituximab in Dermatology. Curr Dermatol Rep. 2022 Oct 06; 1-12. PMID: 36217351.
      Citations:    
    15. Cole C, Vinay K, Borradori L, Amber KT. Insights Into the Pathogenesis of Bullous Pemphigoid: The Role of Complement-Independent Mechanisms. Front Immunol. 2022; 13:912876. PMID: 35874745.
      Citations:    
    16. Cole C, Borradori L, Amber KT. Deciphering the Contribution of BP230 Autoantibodies in Bullous Pemphigoid. Antibodies (Basel). 2022 Jun 28; 11(3). PMID: 35892704.
      Citations:    
    17. Ujiie H, Rosmarin D, Sch?n MP, St?nder S, Boch K, Metz M, Maurer M, Thaci D, Schmidt E, Cole C, Amber KT, Didona D, Hertl M, Recke A, Gra?hoff H, Hackel A, Schumann A, Riemekasten G, Bieber K, Sprow G, Dan J, Zillikens D, Sezin T, Christiano AM, Wolk K, Sabat R, Kridin K, Werth VP, Ludwig RJ. Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases. Front Med (Lausanne). 2022; 9:875492. PMID: 35755063.
      Citations:    
    18. Foschi CM, Maloney C, Amber KT. Pneumocystis-Pneumonie bei einem Patienten mit Rituximab- und IVIG-Therapie gegen Pemphigus vulgaris. J Dtsch Dermatol Ges. 2022 04; 20(4):520-522. PMID: 35446490.
      Citations:    
    19. Foschi CM, Maloney C, Amber KT. Development of Pneumocystis pneumonia in a patient receiving both rituximab and IVIg for pemphigus vulgaris. J Dtsch Dermatol Ges. 2022 04; 20(4):520-521. PMID: 35322556.
      Citations:    
    20. Kneiber D, Kowalski EH, Amber KT. The Immunogenetics of Autoimmune Blistering Diseases. Adv Exp Med Biol. 2022; 1367:173-212. PMID: 35286697.
      Citations:    
    21. Patel PM, Kelm RC, Amber KT. Palbociclib-induced IgA vasculitis. Dermatol Online J. 2021 12 15; 27(12). PMID: 35499449.
      Citations:    
    22. Bao L, Perez White BE, Li J, Patel PM, Amber KT. Gene expression profiling of laminin a3-blocked keratinocytes reveals an immune-independent mechanism of blistering. Exp Dermatol. 2022 04; 31(4):615-621. PMID: 34796550.
      Citations:    
    23. Bao L, Li J, Solimani F, Didona D, Patel PM, Li X, Qian H, Ishii N, Hashimoto T, Hertl M, Amber KT. Subunit-Specific Reactivity of Autoantibodies Against Laminin-332 Reveals Direct Inflammatory Mechanisms on Keratinocytes. Front Immunol. 2021; 12:775412. PMID: 34899732.
      Citations:    
    24. Patel PM, Amber KT. The risk of Pneumocystis pneumonia in patients of?autoimmune blistering disease-reply to letter entitled "Pemphigus management guidelines: A life-saving perspective". J Am Acad Dermatol. 2021 11; 85(5):e289. PMID: 34271032.
      Citations:    
    25. Solimani F, Didona D, Li J, Bao L, Patel PM, Gasparini G, Kridin K, Cozzani E, Hertl M, Amber KT. Characterizing the proteome of bullous pemphigoid blister fluid utilizing tandem mass tag labeling coupled with LC-MS/MS. Arch Dermatol Res. 2022 Nov; 314(9):921-928. PMID: 34152480.
      Citations:    
    26. Bao L, Li J, Perez White BE, Patel PM, Amber KT. Inhibition of dipeptidyl-peptidase 4 induces upregulation of the late cornified envelope cluster in keratinocytes. Arch Dermatol Res. 2022 Nov; 314(9):909-915. PMID: 34089377.
      Citations:    
    27. Patel PM, Jones VA, Behnam CT, Di Zenzo G, Amber KT. A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy. Antibodies (Basel). 2021 05 17; 10(2). PMID: 34067512.
      Citations:    
    28. Kridin K, Hundt JE, Ludwig RJ, Amber KT, Bitan DT, Cohen AD. Melanoma is associated with an increased risk of bullous pemphigoid: a large population-based longitudinal study. Arch Dermatol Res. 2022 Jan; 314(1):77-83. PMID: 33687539.
      Citations:    
    29. Bao L, Chau CS, Lei Z, Hu H, Chan AG, Amber KT, Maienschein-Cline M, Tsoukas MM. Dysregulated microRNA expression in IL-4 transgenic mice, an animal model of atopic dermatitis. Arch Dermatol Res. 2021 Dec; 313(10):837-846. PMID: 33433718.
      Citations:    
    30. Patel PM, Jones VA, Amber KT. Disease-dependent Risk of Pneumocystis Pneumonia: The Case of Autoimmune Blistering Disease. Chest. 2020 12; 158(6):2704-2705. PMID: 33280759.
      Citations:    
    31. Patel PM, Jones VA, Kridin K, Amber KT. The role of Dipeptidyl Peptidase-4 in cutaneous disease. Exp Dermatol. 2021 03; 30(3):304-318. PMID: 33131073.
      Citations:    
    32. Scarsella L, Pollmann R, Amber KT. Autoreactive T cells in pemphigus: perpetrator and target. Ital J Dermatol Venerol. 2021 04; 156(2):124-133. PMID: 33179878.
      Citations:    
    33. Kridin K, Jones VA, Patel PM, Zelber-Sagi S, Hammers CM, Damiani G, Amber KT, Cohen AD. Patients with pemphigus are at an increased risk of developing rheumatoid arthritis: a large-scale cohort study. Immunol Res. 2020 12; 68(6):373-378. PMID: 33159312.
      Citations:    
    34. Snyder A, Valdebran M, Terrero D, Amber KT, Kelly KM. Solar Ultraviolet Exposure in Individuals Who Perform Outdoor Sport Activities. Sports Med Open. 2020 Sep 03; 6(1):42. PMID: 32880767.
      Citations:    
    35. Patel PM, Gibson FT, Amber KT. RECURRENT PEMPHIGUS FOLIACEUS AT THE SITE OF A SURGICAL SCAR FOLLOWING TOTAL KNEE ARTHROPLASTY. J Clin Aesthet Dermatol. 2020 Sep; 13(9):12. PMID: 33133335.
      Citations:    
    36. Kowalski EH, Kneiber D, Lai O, Charny J, Groth JV, Amber KT. Pemphigus vulgaris manifesting as severe oral and epiglottal epithelial dysplasia. J Dtsch Dermatol Ges. 2020 Aug; 18(8):895-896. PMID: 32776681.
      Citations:    
    37. Kowalski EH, Kneiber D, Lai O, Charny J, Groth JV, Amber KT. J Dtsch Dermatol Ges. 2020 Aug; 18(8):895-897. PMID: 33448679.
      Citations:    
    38. Patel PM, Jones VA, Murray TN, Amber KT. A Review Comparing International Guidelines for the Management of Bullous Pemphigoid, Pemphigoid Gestationis, Mucous Membrane Pemphigoid, and Epidermolysis Bullosa Acquisita. Am J Clin Dermatol. 2020 Aug; 21(4):557-565. PMID: 32180161.
      Citations:    
    39. Kridin K, Patel PM, Jones VA, Damiani G, Amber KT, Cohen AD. Hidradenitis suppurativa is associated with acne keloidalis nuchae: a population-based study. Arch Dermatol Res. 2021 Jul; 313(5):333-337. PMID: 32676745.
      Citations:    
    40. Jones VA, Patel PM, Amber KT. Eosinophils in bullous pemphigoid. Panminerva Med. 2021 Sep; 63(3):368-378. PMID: 32536149.
      Citations:    
    41. Jones VA, Patel PM, Gibson FT, Cordova A, Amber KT. The Role of Collagen XVII in Cancer: Squamous Cell Carcinoma and Beyond. Front Oncol. 2020; 10:352. PMID: 32266137.
      Citations:    
    42. Kridin K, Jones VA, Patel PM, Gibson FT, Amber KT, Cohen AD. Hidradenitis suppurativa and pemphigus: a cross-sectional study. Arch Dermatol Res. 2020 Sep; 312(7):501-505. PMID: 32034471.
      Citations:    
    43. Valdebran M, Kowalski EH, Kneiber D, Li J, Kim J, Amber KT. Digital Quantification of Epidermal Protein Expression in Paraffin-Embedded Tissue Using Immunohistochemistry. Methods Mol Biol. 2020; 2109:75-82. PMID: 31190272.
      Citations:    
    44. Kridin K, Patel PM, Jones VA, Cordova A, Amber KT. IgA pemphigus: A systematic review. J Am Acad Dermatol. 2020 Jun; 82(6):1386-1392. PMID: 31812619.
      Citations:    
    45. Gibson FT, Amber KT. Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic review. Int J Dermatol. 2020 May; 59(5):520-524. PMID: 31631316.
      Citations:    
    46. Valdebran M, Kowalski EH, Kneiber D, Li J, Kim J, Doan L, De Feraudy S, Amber KT. Epidermal expression of eotaxins and thymic stromal lymphopoietin in eosinophil rich dermatoses. Arch Dermatol Res. 2019 Nov; 311(9):705-710. PMID: 31350578.
      Citations:    
    47. Kridin K, Kridin M, Amber KT, Shalom G, Comaneshter D, Batat E, Cohen AD. The Risk of Pulmonary Embolism in Patients With Pemphigus: A Population-Based Large-Scale Longitudinal Study. Front Immunol. 2019; 10:1559. PMID: 31396203.
      Citations:    
    48. Kridin K, Kneiber D, Kowalski EH, Valdebran M, Amber KT. Epidermolysis bullosa acquisita: A comprehensive review. Autoimmun Rev. 2019 Aug; 18(8):786-795. PMID: 31181325.
      Citations:    
    49. Kowalski EH, Kneiber D, Valdebran M, Patel U, Amber KT. Distinguishing truly recalcitrant prurigo nodularis from poor treatment adherence: a response to treatment-resistant prurigo nodularis [Response to letter]. Clin Cosmet Investig Dermatol. 2019; 12:371-372. PMID: 31190945.
      Citations:    
    50. Kneiber D, Kowalski EH, Kridin K, Amber KT. Pemphigus subtype: a confounder in determining the association of oral involvement with post-rituximab relapses. Dermatol Ther. 2019 05; 32(3):e12918. PMID: 30977210.
      Citations:    
    51. Kneiber D, Kowalski EH, Amber KT. Dapsone, 2 birds with 1 stone: A response to "Dapsone advantages over trimethoprim-sulfamethoxazole for Pneumocystis pneumonia prophylaxis in immunobullous patients". J Am Acad Dermatol. 2021 12; 85(6):e369. PMID: 31009669.
      Citations:    
    52. Has C, Amber KT, Murrell DF, Musette P, Ludwig RJ. Editorial: Skin Blistering Diseases. Front Med (Lausanne). 2019; 6:60. PMID: 31001533.
      Citations:    
    53. Kowalski EH, Kneiber D, Kridin K, Amber KT. Comment on "Incidence of pneumocystosis among patients exposed to immunosuppression". J Am Acad Dermatol. 2019 08; 81(2):e47. PMID: 30940511.
      Citations:    
    54. Kowalski EH, Kneibner D, Kridin K, Amber KT. Serum and blister fluid levels of cytokines and chemokines in pemphigus and bullous pemphigoid. Autoimmun Rev. 2019 May; 18(5):526-534. PMID: 30844553.
      Citations:    
    55. Kowalski EH, Kneiber D, Valdebran M, Patel U, Amber KT. Treatment-resistant prurigo nodularis: challenges and solutions. Clin Cosmet Investig Dermatol. 2019; 12:163-172. PMID: 30881076.
      Citations:    
    56. Chernyavsky A, Amber KT, Agnoletti AF, Wang C, Grando SA. Synergy among non-desmoglein antibodies contributes to the immunopathology of desmoglein antibody-negative pemphigus vulgaris. J Biol Chem. 2019 03 22; 294(12):4520-4528. PMID: 30692201.
      Citations:    
    57. Yale K, Elsensohn AN, Shiu J, Amber K, Smith J. Erythematous papular rash with sparing of folds. JAAD Case Rep. 2019 Feb; 5(2):135-137. PMID: 30733979.
      Citations:    
    58. Amber KT, Chernyavsky A, Agnoletti AF, Cozzani E, Grando SA. Mechanisms of pathogenic effects of eosinophil cationic protein and eosinophil-derived neurotoxin on human keratinocytes. Exp Dermatol. 2018 12; 27(12):1322-1327. PMID: 30218612.
      Citations:    
    59. Amber KT, Maglie R, Solimani F, Eming R, Hertl M. Targeted Therapies for Autoimmune Bullous Diseases: Current Status. Drugs. 2018 Oct; 78(15):1527-1548. PMID: 30238396.
      Citations:    
    60. Amber KT, Grando SA. Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert survey. Int J Dermatol. 2018 11; 57(11):e125-e126. PMID: 30117648.
      Citations:    
    61. Amber KT, Valdebran M, Grando SA. Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus. Autoimmun Rev. 2018 Oct; 17(10):1002-1010. PMID: 30103046.
      Citations:    
    62. Kridin K, Cohen AD, Amber KT. Underlying Systemic Diseases in Pyoderma Gangrenosum: A Systematic Review and Meta-Analysis. Am J Clin Dermatol. 2018 Aug; 19(4):479-487. PMID: 29721816.
      Citations:    
    63. Amber KT, Valdebran M, Kridin K, Grando SA. The Role of Eosinophils in Bullous Pemphigoid: A Developing Model of Eosinophil Pathogenicity in Mucocutaneous Disease. Front Med (Lausanne). 2018; 5:201. PMID: 30042946.
      Citations:    
    64. Amber KT, Valdebran M, Grando SA. Non-Desmoglein Antibodies in Patients With Pemphigus Vulgaris. Front Immunol. 2018; 9:1190. PMID: 29915578.
      Citations:    
    65. Amber KT, Valdebran M, Makdisi J, De Feraudy S, Balu M, Kelly KM. Multizentrische Retikulohistiozytose in lichtexponierten Arealen: Korrelation mit Multiphotonenmikroskopie-Bildgebung. J Dtsch Dermatol Ges. 2018 Jun; 16(6):781-783. PMID: 29873900.
      Citations:    
    66. Kridin K, Amber K, Khamaisi M, Comaneshter D, Batat E, Cohen AD. Is there an association between dipeptidyl peptidase-4 inhibitors and autoimmune disease? A population-based study. Immunol Res. 2018 06; 66(3):425-430. PMID: 29855994.
      Citations:    
    67. Amber KT, Valdebran M, Makdisi J, De Feraudy S, Balu M, Kelly KM. A case of photodistributed multicentric reticulohistiocytosis: correlation with multiphoton microscopy imaging. J Dtsch Dermatol Ges. 2018 Jun; 16(6):781-783. PMID: 29697904.
      Citations:    
    68. Amber KT. Paraneoplastic autoimmune multi-organ syndrome is a distinct entity from traditional pemphigus subtypes. Nat Rev Dis Primers. 2018 02 22; 4:18012. PMID: 29469089.
      Citations:    
    69. Amber KT, Murrell DF, Schmidt E, Joly P, Borradori L. Autoimmune Subepidermal Bullous Diseases of the Skin and Mucosae: Clinical Features, Diagnosis, and Management. Clin Rev Allergy Immunol. 2018 Feb; 54(1):26-51. PMID: 28779299.
      Citations:    
    70. Amber KT, Valdebran M, Lu Y, De Feraudy S, Linden KG. Localized pretibial bullous pemphigoid arising in a patient on pembrolizumab for metastatic melanoma. J Dtsch Dermatol Ges. 2018 Feb; 16(2):196-198. PMID: 29389067.
      Citations:    
    71. Amber KT, Valdebran M, Lu Y, De Feraudy S, Linden KG. Lokalisiertes pr?tibiales bull?ses Pemphigoid bei einer Patientin unter Pembrolizumab-Therapie wegen eines metastasierten Melanoms. J Dtsch Dermatol Ges. 2018 Feb; 16(2):196-198. PMID: 29418094.
      Citations:    
    72. Lehmer LM, Amber KT, de Feraudy SM. Syringotropic Mycosis Fungoides: A Rare Form of Cutaneous T-cell Lymphoma Enabling a Histopathologic "Sigh of Relief". Am J Dermatopathol. 2017 Dec; 39(12):920-923. PMID: 28692463.
      Citations:    
    73. Vinay K, Cazzaniga S, Amber KT, Feldmeyer L, Naldi L, Borradori L. Rituximab as first-line adjuvant therapy for pemphigus: Retrospective analysis of long-term outcomes at a single center. J Am Acad Dermatol. 2018 04; 78(4):806-808. PMID: 29146127.
      Citations:    
    74. Valdebran M, Amber KT. Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US Insurers. JAMA Dermatol. 2017 11 01; 153(11):1189-1190. PMID: 28813559.
      Citations:    
    75. Amber KT, Lamberts A, Solimani F, Agnoletti AF, Didona D, Euverman I, Cozzani E, Yueh LH, Di Zenzo G, Leshem YA, Mimouni D, Hertl M, Horvath B. Determining the Incidence of Pneumocystis Pneumonia in Patients With Autoimmune Blistering Diseases Not Receiving Routine Prophylaxis. JAMA Dermatol. 2017 11 01; 153(11):1137-1141. PMID: 28854309.
      Citations:    
    76. Kamel JG, Amber KT. Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issue. Int J Dermatol. 2018 01; 57(1):113. PMID: 29047113.
      Citations:    
    77. Amber KT, Panganiban CM, Korta D, Feraudy S, Kelly KM, Grando SA. A case report of bullous pemphigoid associated with a melanoma and review of the literature. Melanoma Res. 2017 02; 27(1):65-67. PMID: 27759577.
      Citations:    
    78. Bloom R, Amber KT. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials. An Bras Dermatol. 2017 Jan-Feb; 92(1):139-141. PMID: 28225977.
      Citations:    
    79. Amber KT. Balancing the risks and benefits of prophylaxis: a reply to "Pneumocystis jiroveci pneumonia in patients treated with systemic immunosuppressive agents for dermatologic conditions". Int J Dermatol. 2017 01; 56(1):e4-e5. PMID: 27653175.
      Citations:    
    80. Amber KT, Bloom R, Abyaneh MY, Falto-Aizpurua LA, Viera M, Zaiac MN, Nouri K, Hu S. Patient Factors and Their Association with Nonmelanoma Skin Cancer Morbidity and the Performance of Self-skin Exams: A Cross-Sectional Study. J Clin Aesthet Dermatol. 2016 Sep; 9(9):16-22. PMID: 27878058.
      Citations:    
    81. Amber KT, Kodiyan J, Bloom R, Hertl M. The controversy of hepatitis C and rituximab: A multidisciplinary dilemma with implications for patients with pemphigus. Indian J Dermatol Venereol Leprol. 2016 Mar-Apr; 82(2):182-3. PMID: 26585844.
      Citations:    
    82. Amber KT, Bloom R, Nouri K. Second Primary Malignancies in CTCL Patients from 1992 to 2011: A SEER-Based, Population-Based Study Evaluating Time from CTCL Diagnosis, Age, Sex, Stage, and CD30+ Subtype. Am J Clin Dermatol. 2016 Feb; 17(1):71-7. PMID: 26386881.
      Citations:    
    83. Amber KT, Bloom R, Hu S. Association of Google Search Volume Index Peaks for Skin Cancer With Skin Cancer Awareness Month--Reply. JAMA Dermatol. 2016 Jan; 152(1):113-4. PMID: 26762258.
      Citations:    
    84. Amber KT, Bunyan A, Lee JJ, Duvvuri A. Granulomatosis with polyangiitis (GPA) initially presenting as sigmoiditis with the later development of spontaneous subcapsular hematoma. Int J Colorectal Dis. 2016 Jul; 31(7):1365-6. PMID: 26715433.
      Citations:    
    85. Di Zenzo G, Amber KT, Sayar BS, M?ller EJ, Borradori L. Immune response in pemphigus and beyond: progresses and emerging concepts. Semin Immunopathol. 2016 Jan; 38(1):57-74. PMID: 26597100.
      Citations:    
    86. Amber KT. Is anti-BP180 IgE associated with clinical phenotype? A reply to 'Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid'. Arch Dermatol Res. 2016 Jan; 308(1):65-6. PMID: 26590973.
      Citations:    
    87. Kodiyan J, Amber KT. Topical antioxidants in radiodermatitis: a clinical review. Int J Palliat Nurs. 2015 Sep; 21(9):446-52. PMID: 26412275.
      Citations:    
    88. Brooks L, Hadi J, Amber KT, Weiner M, La Riche CL, Ference T. Assessing the prevalence of autoimmune, endocrine, gynecologic, and psychiatric comorbidities in an ethnically diverse cohort of female fibromyalgia patients: does the time from hysterectomy provide a clue? J Pain Res. 2015; 8:561-9. PMID: 26316807.
      Citations:    
    89. Patel R, Amber KT. Thrombotic thrombocytopenic purpura in a postoperative patient taking cephalexin responding to plasmapheresis: A case report and review of cephalosporin-induced TTP. J Clin Apher. 2016 Oct; 31(5):473-5. PMID: 26274019.
      Citations:    
    90. Bloom R, Amber KT, Hu S, Kirsner R. Google Search Trends and Skin Cancer: Evaluating the US Population's Interest in Skin Cancer and Its Association With Melanoma Outcomes. JAMA Dermatol. 2015 Aug; 151(8):903-5. PMID: 26061357.
      Citations:    
    91. Bloom R, Amber KT. Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United States. J Am Acad Dermatol. 2015 Aug; 73(2):337-8. PMID: 26183986.
      Citations:    
    92. Amber KT. Considerations for the utilization of 'comparative analysis of colorimetric staining in skin using open-source software' in an experimental setting. Exp Dermatol. 2015 Sep; 24(9):717-8. PMID: 25939789.
      Citations:    
    93. Kodiyan J, Amber KT. A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin Reactions. Antioxidants (Basel). 2015 Apr 23; 4(2):293-303. PMID: 26783706.
      Citations:    
    94. Lee J, Bloom R, Amber KT. A Systematic Review of Patients with Mucocutaneous and Respiratory Complications in Paraneoplastic Autoimmune Multiorgan Syndrome: Castleman's Disease is the Predominant Malignancy. Lung. 2015 Aug; 193(4):593-6. PMID: 25903794.
      Citations:    
    95. Bloom R, Amber KT, Nouri K. An increased risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia in US patients with Merkel cell carcinoma versus Australian patients: A clinical clue to a different mechanism of pathogenesis? Australas J Dermatol. 2016 Aug; 57(3):e114-6. PMID: 25801041.
      Citations:    
    96. Dhiman GJ, Amber KT, Goodman KW. Comparative outcome studies of clinical decision support software: limitations to the practice of evidence-based system acquisition. J Am Med Inform Assoc. 2015 Apr; 22(e1):e13-20. PMID: 25665704.
      Citations:    
    97. Amber KT, Ledon JA, Savas JA, Dusseault SK, Nouri K. Visual identification of skin cancer in beachgoers: a need for improved education on non-melanoma skin cancer in the general population and melanoma in the African-American population. Int J Dermatol. 2015 Mar; 54(3):e85-7. PMID: 25515041.
      Citations:    
    98. Amber KT, Ovadia S, Camacho I. Injection therapy for the management of superficial subcutaneous lipomas. J Clin Aesthet Dermatol. 2014 Jun; 7(6):46-8. PMID: 25013540.
      Citations:    
    99. Amber KT, Bloom R, Staropoli P, Dhiman S, Hu S. Assessing the current market of sunscreen: a cross-sectional study of sunscreen availability in three metropolitan counties in the United States. J Skin Cancer. 2014; 2014:285357. PMID: 24955250.
      Citations:    
    100. Amber KT, Landy DC, Amber I, Knopf D, Guerra J. Comparing the accuracy of ultrasound versus fluoroscopy in glenohumeral injections: a systematic review and meta-analysis. J Clin Ultrasound. 2014 Sep; 42(7):411-6. PMID: 24668738.
      Citations:    
    101. Amber KT, Winslow CY, Styperek A, Schwartz PH, Shiman MI, Elgart G. Blue skin. Int J Dermatol. 2014 Mar; 53(3):275-6. PMID: 24571592.
      Citations:    
    102. Amber KT, Dhiman G, Goodman KW. Conflict of interest in online point-of-care clinical support websites. J Med Ethics. 2014 Aug; 40(8):578-80. PMID: 24493079.
      Citations:    
    103. Amber KT. If students cannot deliver bad news, they should not be the first to see patients awaiting bad news. Acad Med. 2014 Jan; 89(1):9. PMID: 24370913.
      Citations:    
    104. Amber KT, Brooks L, Ference TS. Does improved confidence in a disease relate to increased knowledge? Our experience with medical students. Pain Med. 2014 Mar; 15(3):483-4. PMID: 24308417.
      Citations:    
    105. Dhiman GJ, Amber KT. Pharmaceutical ethics and physician liability in Side Effects. J Med Humanit. 2013 Dec; 34(4):497-503. PMID: 23996742.
      Citations:    
    106. Amber KT, Staropoli P, Shiman MI, Elgart GW, Hertl M. Autoreactive T cells in the immune pathogenesis of pemphigus vulgaris. Exp Dermatol. 2013 Nov; 22(11):699-704. PMID: 24433179.
      Citations:    
    107. Amber KT. Artist's statement: The Sight of Sickness. Acad Med. 2013 Aug; 88(8):1080. PMID: 23899855.
      Citations:    
    108. Amber KT, Shiman MI, Badiavas EV. The use of antioxidants in radiotherapy-induced skin toxicity. Integr Cancer Ther. 2014 Jan; 13(1):38-45. PMID: 23729466.
      Citations:    
    109. Amber K, Brooks L, Ference T. Direct to consumer advertising's effect on medical students: the case of fibromyalgia. Med Teach. 2013 Nov; 35(11):969-70. PMID: 23631407.
      Citations:    
    110. Parikh PP, Amber KT, Angeli SI. A schwannoma of the greater petrosal nerve located within the petrous apex and treated with stereotactic radiotherapy. Am J Otolaryngol. 2013 Sep-Oct; 34(5):596-9. PMID: 23499495.
      Citations:    
    111. Amber KT. Complete spontaneous regression of merkel cell carcinoma. Glob Adv Health Med. 2013 Mar; 2(2):7-8. PMID: 24416659.
      Citations:    
    112. Amber K, McLeod MP, Nouri K. The Merkel cell polyomavirus and its involvement in Merkel cell carcinoma. Dermatol Surg. 2013 Feb; 39(2):232-8. PMID: 23387356.
      Citations:    
    113. Amber KT, Casta?o JE, Angeli SI. Prophylactic valacyclovir in a patient with recurrent vestibular disturbances secondary to vestibular neuritis. Am J Otolaryngol. 2012 Jul-Aug; 33(4):487-8. PMID: 22154065.
      Citations:    
    Amber's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (347)
    Explore
    _
    Co-Authors (1)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _